SCHEMBL19995657

SCHEMBL19995657

COC(=O)CCCCCCC/C=C/COC(C)=O

nearest known ligand 0.54

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.54
LMNA P02545 2/20 0.54
EPHX2 P34913 1/20 0.54
PRKCA P17252 1/20 0.48
TSHR P16473 2/20 0.46
CYP3A4 P08684 2/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CNR2 P34972 1/20 0.43
ALOX5 P09917 2/20 0.43
OXER1 Q8TDS5 1/20 0.43
DGKA P23743 1/20 0.42
RECQL P46063 2/20 0.42
USP2 O75604 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6511753 1.00 ALDH1A1 (0.54) ALDH1A1LMNAEPHX2PRKCATSHR
SCHEMBL19996018 1.00 ALDH1A1 (0.54) ALDH1A1LMNAEPHX2PRKCATSHR
SCHEMBL6511747 1.00 ALDH1A1 (0.54) ALDH1A1LMNAEPHX2PRKCATSHR
SCHEMBL19996019 1.00 ALDH1A1 (0.54) ALDH1A1LMNAEPHX2PRKCATSHR
SCHEMBL19995658 1.00 ALDH1A1 (0.54) ALDH1A1LMNAEPHX2PRKCATSHR
SCHEMBL2834472 0.87 ALDH1A1 (0.54) ALDH1A1LMNAEPHX2PRKCATSHR
SCHEMBL17870902 0.87 ALDH1A1 (0.54) ALDH1A1LMNAEPHX2PRKCATSHR
SCHEMBL17870903 0.87 ALDH1A1 (0.54) ALDH1A1LMNAEPHX2PRKCATSHR
SCHEMBL4306967 0.87 ALDH1A1 (0.54) ALDH1A1LMNAEPHX2PRKCATSHR
SCHEMBL17870915 0.87 ALDH1A1 (0.54) ALDH1A1LMNAEPHX2PRKCATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3515885-B1 PREPARATION OF AMINO ACIDS AND AMINO ACID DERIVATIVES UMICORE AG & CO KG (DE) 2023-12-13 EP claimed
CN-109982995-B Preparation of amino acids and amino acid derivatives 优美科股份公司及两合公司 2022-09-30 CN claimed
US-10774035-B2 Preparation of amino acids and amino acid derivatives UMICORE AG & CO. KG (DE) 2020-09-15 US claimed
US-20190276388-A1 PREPARATION OF AMINO ACIDS AND AMINO ACID DERIVATIVES UMICORE AG & CO KG (DE) 2019-09-12 US claimed
EP-3515885-B1 PREPARATION OF AMINO ACIDS AND AMINO ACID DERIVATIVES UMICORE AG & CO KG (DE) 2023-12-13 EP disclosed
CN-109982995-B Preparation of amino acids and amino acid derivatives 优美科股份公司及两合公司 2022-09-30 CN disclosed
US-10774035-B2 Preparation of amino acids and amino acid derivatives UMICORE AG & CO. KG (DE) 2020-09-15 US disclosed
US-20190276388-A1 PREPARATION OF AMINO ACIDS AND AMINO ACID DERIVATIVES UMICORE AG & CO KG (DE) 2019-09-12 US disclosed
EP-3515885-A1 PREPARATION OF AMINO ACIDS AND AMINO ACID DERIVATIVES UMICORE AG & CO. KG (DE) 2019-07-31 EP disclosed
WO-2018057290-A1 PREPARATION OF AMINO ACIDS AND AMINO ACID DERIVATIVES MATERIA, INC. (US) 2018-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190276388-A1 PREPARATION OF AMINO ACIDS AND AMINO ACID DERIVATIVES AADAT, BCAT1, BCAT2 ALDH1A1 911/4885LMNA 3915/4885EPHX2 3117/4885
US-10774035-B2 Preparation of amino acids and amino acid derivatives AADAT, BCAT1, BCAT2 ALDH1A1 911/4885LMNA 3915/4885EPHX2 3117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.